Archer Materials
Archer Materials (ASX: AXE) is an Australian pre-revenue quantum technology company developing the 12CQ carbon-based quantum computing chip and a graphene-based Biochip for point-of-care blood diagnostics, licensing its IP to semiconductor, MedTech, and quantum partners.
- Company typePublic
- Founded2007
- HeadquartersUnley, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Archer Materials does
Archer Materials Limited (ASX: AXE) is an Australian quantum technology company developing two core platforms built on carbon-based semiconductor materials: the 12CQ chip, a carbon-nano-onion and graphene-based quantum computing and sensing component designed to be compatible with standard CMOS fabrication and operable at higher temperatures than conventional quantum processors, and the Biochip, a graphene field-effect transistor (gFET) biosensor targeting point-of-care blood diagnostics, with an initial application in blood potassium monitoring for chronic kidney disease, cardiovascular, and diabetes patients. Supporting technologies include on-chip Electrical Detection of Magnetic Resonance (EDMR), Single-Electron Transistor (SET) architectures for qubit readout, and graphene-based device platforms co-developed with Paragraf.
The company operates a capital-light IP licensing and partnership model rather than building complete quantum machines, targeting licensees across semiconductor manufacturing, quantum computing, and MedTech. Revenue is currently nil; the company is funded by equity raises (a A$15 million institutional placement in 2025) and Australian R&D tax incentives (A$2.1 million rebate received in January 2026), with cash of approximately A$10.3 million as of December 2025 providing an estimated 7.9 quarters of runway. Strategic partnerships include a three-year US$1.5 million agreement with IonQ to evaluate Australian deployment of IonQ's quantum systems, R&D alliances with IMEC (silicon-integrated biochip), CSIRO (quantum machine learning for fraud detection), Emergence Quantum, Paragraf, QMUL, and EPFL, and a historical partnership with IBM dating to 2020.
The company is led by co-founder and Executive Chairman Greg English and CEO Dr Simon Ruffell (appointed March 2025, previously Principal Hardware Engineering Manager at Microsoft and Senior Manager at Applied Materials), with a lean team of 11-50 employees split between offices in Sydney and Adelaide (Lot Fourteen). Target end-markets span healthcare and medical diagnostics, defense and government (including GPS-denied navigation and sovereign quantum capability), AI and advanced computing, mining and resources, and financial services, with operating geographies currently focused on Australia and the broader APAC region.
Archer Materials firmographics
Firmographics- Name
- Archer Materials
- Legal name
- Archer Materials Limited
- Website
- https://archerx.com.au
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Archer Materials (ASX: AXE) is an Australian pre-revenue quantum technology company developing the 12CQ carbon-based quantum computing chip and a graphene-based Biochip for point-of-care blood diagnostics, licensing its IP to semiconductor, MedTech, and quantum partners.
- Ownership category
- akta.pro rank
Archer Materials industry classification
Industry- Product category
- Quantum Computing Hardware
- NAICS
- Semiconductor and Related Device Manufacturing (334413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Semiconductors & Related Devices (3674), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)
Keywords
Where Archer Materials is headquartered
LocationHeadquarters
- HQ city
- Unley
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Archer Materials business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Revenue model
- IP Licensing: Archer Materials develops intellectual property designed to integrate with established semiconductor ecosystems and licenses this IP through industry partnerships rather than constructing complete quantum computing systems. Value is created through IP development and strategic collaboration.
- Quantum Cloud Services (IonQ Agreement): Three-year Quantum Compute Agreement with IonQ provides access to quantum simulator, advisory services, and Forte-class/Tempo-class quantum systems for Australian deployment assessment and customer base development.
- Quantum Sensing Devices: Quantum sensing applications for magnetometry, medical diagnostics, and GPS-denied navigation environments using carbon-based technology platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | IonQ Quantum Compute Agreement - Three-year access package |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Archer Materials product offering
Product offeringCore offering
Archer Materials develops two primary technology platforms: the 12CQ chip, a carbon-based quantum computing and sensing chip built from carbon nano onions and graphene that is compatible with standard semiconductor fabrication processes, and the Biochip, a graphene field-effect transistor (gFET) ion-sensing biosensor for point-of-care medical diagnostics beginning with blood potassium monitoring. The company operates an IP licensing and partnership commercialization model, monetizing its technology through agreements with MedTech manufacturers, semiconductor companies, defense agencies, and research institutions rather than producing finished consumer products.
Product overview
Archer Materials is developing a dual-platform technology portfolio comprising the 12CQ quantum computing chip and the Biochip biosensing platform. The 12CQ chip is a carbon-based quantum hardware component targeting qubit demonstration and quantum sensing applications, designed to integrate with existing semiconductor manufacturing infrastructure rather than building full-scale quantum machines. The Biochip is a silicon-integrated graphene field-effect transistor (gFET) biosensor for point-of-care medical diagnostics, beginning with blood potassium monitoring for chronic kidney disease. Both platforms share a common carbon-materials foundation, enabling knowledge transfer and capital efficiency across programs. The company operates a capital-light IP-licensing model, pursuing partnerships with research institutions and industry players to commercialize its technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- 12CQ Chip The 12CQ Chip is a carbon-based quantum computing chip and sensing platform designed for scalable qubit demonstration and advanced quantum sensing. It leverages carbon quantum materials (carbon nano onions and graphene) that are compatible with standard semiconductor fabrication processes, targeting applications in quantum computing, precision magnetometry, and medical diagnostics. The chip is designed to be smaller, more cost-effective, and operable at higher temperatures than conventional quantum processors.
- Biochip The Biochip is a graphene-based ion-sensing biosensor platform (gFET) integrated into a lab-on-a-chip cartridge for point-of-care medical diagnostics. The initial application targets rapid, low-cost blood potassium monitoring for chronic kidney disease patients, with planned extension to other ion-sensing applications across health, agriculture, and industry. A beta prototype is targeted for 2026 to support clinical trial initiation and licensing negotiations with MedTech companies.
Quantifiable outcome
- Blood potassium measurement accuracy within ±0.3 mM, meeting CLIA requirements
- +2 more outcomes
Companies that use Archer Materials
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Archer Materials technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Archer Materials partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, core and supporting.
- IonQflagshipThree-year Quantum Compute Agreement providing Archer access to IonQ's Quantum Cloud, advisory services, and Forte-class/Tempo-class quantum systems. Archer will pay US$250,000 on signing plus US$250,000 every six months (US$1.5 million total). Partnership aims to assess feasibility of deploying an IonQ quantum computer in Australia to establish sovereign quantum computing capability.
- ParagrafcoreCooperative R&D program to develop graphene-based quantum devices for next-generation quantum computing hardware. Collaboration combines Paragraf's commercially scalable graphene manufacturing with Archer's expertise in quantum device architectures to create novel qubit detection architectures. Goal is to generate differentiated graphene-based technologies for quantum computing, advanced sensing, and next-generation electronics.
- CSIROcore12-month research services agreement to develop Quantum Machine Learning (QML) models for fraud detection in financial transactions. Project focuses on developing hybrid quantum-classical models with prototype quantum models and performance benchmarks across simulated financial datasets. Builds upon CSIRO's expertise in QML model development.
- IMEC (Interuniversity Microelectronics Centre)corePartnership to develop silicon-integrated Biochip for blood potassium sensing. IMEC leverages semiconductor technology and expertise to enable graphene and silicon-based devices during testing. First results confirmed silicon devices meet blood potassium accuracy requirements and clinical CLIA standards, with shorter conditioning times of ~30 minutes.
- Emergence QuantumcoreTwo-phase Innovation and Commercialisation Program focusing on graphene and carbon-based materials for quantum and non-quantum applications. Phase I involves mapping graphene's potential across quantum domains; Phase II involves experimental validation and prototype development. Emergence Quantum brings world-class capability and experience from work with multinational quantum companies.
- Queen Mary University of London (QMUL)supportingCollaboration on qubit development, including extended partnership agreement for carbon qubit research and EDMR breakthrough progress.
- École Polytechnique Fédérale de Lausanne (EPFL)supportingResearch collaboration to improve electron spin coherence for qubits. Validated model by engineering atomic defects like carbon vacancies and hydrogen chemisorption in carbon nanosphere material, showing spin polarisation spreads over ~5 nm.
- IBMsupportingHistorical partnership announced in 2020 where Archer claimed to be the first Australian company building a quantum computing processor and hardware, with the CQ qubit processor chip.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Archer Materials competitors and assessment
Company assessmentDirect peers
- IonQ: Trapped-ion quantum computing company developing quantum hardware and cloud-access services. Directly comparable as a quantum computing hardware platform; also a strategic partner of Archer via the three-year Quantum Compute Agreement.
- PsiQuantum: Photonic quantum computing company pursuing fault-tolerant quantum systems at scale. Comparable in its pursuit of a fundamentally different quantum hardware modality aimed at overcoming the limitations of superconducting and trapped-ion approaches.
- Paragraf: UK-based company commercializing graphene-based electronic devices including sensors. Directly comparable as a graphene-electronics hardware company; also an active R&D partner of Archer in developing graphene-based quantum devices.
- Rigetti Computing: Publicly listed superconducting quantum computing hardware developer offering cloud quantum services. Comparable as a small-cap, pre-commercial quantum hardware company pursuing a similar pathway of building quantum IP and partner-based commercial scale-up.
- Quantum Computing Inc. Small-cap quantum hardware and software company developing quantum sensing, computing, and cybersecurity solutions. Closely comparable as a publicly listed, pre-revenue quantum technology company pursuing multiple end-market applications.
- D-Wave Quantum: Publicly listed quantum computing company selling annealing quantum systems and quantum cloud access. Comparable as a small-cap, publicly listed pure-play quantum hardware company with similar capitalization profile and commercialization timeline.
- Quantinuum: Trapped-ion quantum computing company formed from Honeywell and Cambridge Quantum. Comparable as a developer of full-stack quantum hardware and software pursuing commercial quantum advantage.
Broad incumbents
- Abbott Point of Care: Major medical device company operating the i-STAT point-of-care blood diagnostics platform. Comparable as a broad incumbent in point-of-care diagnostics that could be a potential licensing or acquisition target for Archer's Biochip technology.
- IBM Quantum: Division of IBM offering superconducting quantum hardware, Qiskit software platform, and quantum cloud services. Comparable as the broad incumbent in quantum computing with whom Archer has historical partnership ties; represents the scale and resources against which Archer competes.
Emerging players
- Graphenea: Graphene materials supplier and developer of graphene-based biosensors and electronic devices. Comparable as a graphene technology company working on biosensing applications overlapping with Archer's Biochip platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Archer Materials social profiles
Digital presenceArcher Materials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Archer Materials leadership team
Management profileNumber of profiles
Profiles6 records
Archer Materials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Archer Materials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Archer Materials
What does Archer Materials do?
Archer Materials develops two primary technology platforms: the 12CQ chip, a carbon-based quantum computing and sensing chip built from carbon nano onions and graphene that is compatible with standard semiconductor fabrication processes, and the Biochip, a graphene field-effect transistor (gFET) ion-sensing biosensor for point-of-care medical diagnostics beginning with blood potassium monitoring. The company operates an IP licensing and partnership commercialization model, monetizing its technology through agreements with MedTech manufacturers, semiconductor companies, defense agencies, and research institutions rather than producing finished consumer products.
Is Archer Materials a public or private company?
Archer Materials is a public company. It is classified as public and is currently operating.
When was Archer Materials founded?
Archer Materials was founded in 2007. It employs 11 to 50 people.
Where is Archer Materials based?
Archer Materials is headquartered in Unley, Australia, in the Oceania region.
How does Archer Materials make money?
Three revenue lines are on record. IP Licensing is the primary driver. The others are quantum Cloud Services (IonQ Agreement) and quantum Sensing Devices.
Who are Archer Materials's main competitors?
Direct peers on record are IonQ, PsiQuantum, Paragraf, Rigetti Computing, Quantum Computing Inc., D-Wave Quantum and Quantinuum. Broad incumbents are Abbott Point of Care and IBM Quantum. Graphenea is listed as an emerging player.
Does Archer Materials have an API?
No public API is recorded for Archer Materials.
What industry is Archer Materials in?
Archer Materials's product category is Quantum Computing Hardware. Its primary akta.pro industry code is HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS). Its NAICS code is 334413 and its SIC code is 3674.